Advertisement

Trump announces plan to cap Medicare insulin copays at $35

1/4
President Donald Trump speaks during an event on protecting seniors with diabetes Tuesday in the Rose Garden of the White House. Photo by Oliver Contreras/UPI
President Donald Trump speaks during an event on protecting seniors with diabetes Tuesday in the Rose Garden of the White House. Photo by Oliver Contreras/UPI | License Photo

May 26 (UPI) -- President Donald Trump and the Centers for Medicare and Medicaid Services on Tuesday unveiled a plan that will cap costs on insulin for Medicare patients.

The plan will cap the cost of insulin copays for more than 1,750 standalone Medicare Part D prescription drug plans and Medicare Advantage plans for seniors at $35 for a month's supply for the 2021 plan year.

Advertisement

"For hundreds and thousands of seniors enrolled in Medicare, participating plans will cap costs at just $35 a month per type of insulin and some plans may offer it free," Trump said.

The Part D Senior Savings Model was announced in March to serve as a voluntary model that tests the impact on insulin access and care, with participating members paying lower out-of-pocket costs for insulin.

Trump and CMS stated that seniors could see average out-of-pocket savings of $446, or 66 percent, for their insulin under the plan.

"This market-based solution, in which insulin manufacturers and Part D sponsors compete to provide lower costs and higher quality for patients, will allow seniors to choose a Part D plan that covers their insulin at an average 66 percent lower out-of-pocket costs throughout the year," CMS Administrator Seema Verma said.

Advertisement

Part D Senior Savings plans will be available to beneficiaries in the 2021 plan year on Medicare.gov during the annual Affordable Care Act open enrollment period.

Latest Headlines

Advertisement
Advertisement

Follow Us

Advertisement